Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Intermittent Fasting Diet on Metabolic Syndrome Biomarkers and Weight Management in Individuals With Metabolic Syndrome

NCT04502329 is registered in ClinicalTrials.gov with Istanbul Medipol University Hospital as lead sponsor.

NCT NCT04502329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04502329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Intermittent Fasting Diet on Metabolic Syndrome Biomarkers and Weight Management in Individuals With Metabolic Syndrome
Lead sponsor
Istanbul Medipol University Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 30, 2019
Completion date
June 10, 2020
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome